Hyperexpression and activation of extracellular signal-regulated kinases (ERK1/2) in atherosclerotic lesions of cholesterol-fed rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 1, 2000, Pages 18-26

  Hu, Yanhua ^a   Dietrich, Hermann ^a   Metzler, Bernhard ^b   Wick, Georg ^a,c   Xu, Qingbo ^c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

Animal models; Atherosclerosis; ERK; MAP kinases; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME ACTIVATION; EXPERIMENTAL MODEL; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION;

EID: 0033954661     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.1.18     Document Type: Article

References (49)

1. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;268:14553-14556.
2. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9: 726-735.
3. Zou Y, Hu Y, Metzler B, Xu Q. Signal transduction in arteriosclerosis: mechanical stress-activated MAP kinases in vascular smooth muscle cells, Int J Mol Med. 1998;1:827-834.
4. Ray LB, Sturgill TW. Characterization of insulin-stimulated microtubule-associated protein kinase: rapid isolation and stabilization of a novel serine/threonine kinase from 3T3-L1 cells. J Biol Chem. 1988;263: 12721-12727.
5. Sturgill TW, Ray LB, Erikson E, Maller JL. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature. 1988;334:715-718.
6. Lin L-L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993;72:269-278.
7. Chen R-H, Abate C, Blenis J. Phosphorylation of the c-fos transcription domain by MAP kinase and 90-kDa S6 kinase. Proc Natl Acad Sci U S A. 1993;90:10952-10956.
8. Tamemoto H, Kadowaki T, Tobe K, Ueki K, Izumo T, Chatani Y, Kohno M, Yazaki Y, Akanuma Y. Biphasic activation of two mitogen-activated protein kinases during cell cycle in mammalian cells. J Biol Chem. 1992;267:20293-20297.
9. s6 k function is essential for G1 progression. Nature. 1993;363:170-172.
10. mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A. 1993;90: 8319-8323.
11. Brown SM, Goldstein LJ. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-37.
12. Libby P, Miao P, Ordovas JM, Schäfer EJ. Lipoproteins increase growth of mitogen stimulated arterial smooth muscle cells. J Cells Physiol. 1985; 124:1-8.
13. Scott-Burden T, Resink TJ, Hahn AW, Baur U, Box RJ, Buehler FR. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem. 1989;264: 12582-12589.
14. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
15. Sachinidis A, Ko Y, Wieczorek A, Weisser B, Locher R, Vetter W, Vetter H. Lipoproteins induce expression of the early growth response gene-1 in vascular smooth muscle cells from rat. Biochem Biophys Res Commun. 1993;192:794-799.
16. Xu Q, Dietrich H, Steiner HJ, Gown AM, Mikuz G, Kaufmann SHE, Wick G. Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb. 1992;12: 789-799.
17. Xu Q, Kleindienst R, Waitz W, Dietrich H, Wick G. Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest. 1993;91:2693-2702.
18. 2-terminal protein kinases in tissues of heat-stressed mice. J Biol Chem. 1997;272:9113-9119.
19. Hu Y, Böck G, Wick G, Xu Q. Activation of PDGF receptor α in vascular smooth muscle cells by mechanical stress. FASEB J. 1998;12:1135-1142.
20. Ross R, Kariya B. Smooth muscle cells in culture. In: Bohr DF, Somlyo AP, and Sparks HV, eds. Handbook of Physiology: Circulation, Vascular Smooth Muscle. Bethesda, Md: American Physiological Society; 1980: 69-91.
21. Xu Q, Hu Y, Kleindienst R, Wick G. Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1. J Clin Invest. 1997;100:1089-1097.
22. Jürgens G, Xu Q, Huber LA, Böck G, Howanietz H, Wick G, Traill KN. Promotion of lymphocyte growth by high density lipoproteins (HDL): physiological significance of the HDL binding site. J Biol Chem. 1989; 264:8549-8556.
23. Xu Q, Jürgens G, Huber LA, Böck G, Wolf H, Wick G. Lipid utilization by human lymphocytes is correlated with high-density-lipoprotein binding site activity. Biochem J. 1992;285:105-112.
24. Tsukada T, Rosenfeld M, Ross R, Gown AM. Immunocytochemical analysis of cellular components in lesions of atherosclerosis in the Watanabe and fat-fed rabbit using monoclonal antibodies. Arteriosclerosis. 1986;6:601-613.
25. Force T, Bonvemtre JV. Growth factors and mitogen-activated protein kinases. Hypertension. 1998;31:152-161.
26. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997;9:180-186.
27. Blenis J. Signal transduction via MAP kinase: proceed at your own RSK. Proc Natl Acad Sci U S A. 1994;90:5889-5892.
28. Brunet A, Pages G, Pouyssegur J. Constitutively active mutants of MAP kinase kinase induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene. 1994;9:3379-3387.
29. Chamley-Campbell JH, Campbell GR, Ross R. The smooth muscle cell in culture. Am Physiol Soc. 1979;58:1-61.
30. Caplice NM, West MJ, Campbell GR, Campbell J. Inhibition of human vascular smooth muscle cell growth by heparin. Lancet. 1994;344:97-98.
31. Libby P, Hansson GK. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 1991;64:5-15.
32. Xu Q, Oberhuber G, Gruschwitz M, Wick G. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol. 1990;56:344-359.
33. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251: 788-791.
34. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992;140:665-673.
35. Printseva O, Peclo MM, Gown AM. Various cell types in human atherosclerotic lesions express ICAM-1: further immunocytochemical and immunochemical studies employing monoclonal antibody 10F3. Am J Pathol. 1992;140:889-896.
36. Libby P, Li H. Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. J Clin Invest. 1993;92:538-539.
37. Deigner H-P, Claus R. Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cells. FEBS Lett. 1996;385:149-153.
38. Kusuhara M, Chait A, Cader A, Berk BC. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol. 1997;17:141-148.
39. Sachinidis A, Seewald S, Epping P, Seul C, Ko Y, Vetter H. The growth-promoting effect of low-density lipoprotein may be mediated by a pertussis toxin-sensitive mitogen-activated protein kinase pathway. Mol Pharmacol. 1997;52:389-397.
40. Augé N, Eseargueil-Blanc I, Nègre-Salvayre A. Salvayre R. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein. J Biol Chem. 1998;273:12893-12900.
41. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook NJ. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest. 1996;97:508-514.
42. Traub O, Berk BC, Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol. 1998;18:677-685.
43. Sugden PH, Clerk A. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res. 1998;83:345-352.
44. Glennon PE, Kaddoura S, Sale EM, Sale GJ, Fuller SJ, Sugden PH. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res. 1996; 78:954-961.
45. Sun H, Tonks NK, Bar-Sagi D. Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science. 1994;266: 285-288.
46. Liu Y, Gorospe M, Yang C, Holbrook NJ. Role of mitogen-activated protein kinase phosphatase during the cellular response to genotoxic stress. J Biol Chem. 1995;270:8377-8380.
47. Xu Q, Fawcett TW, Gorospe G, Guyton KZ, Liu Y, Holbrook NJ. Induction of mitogen-activated protein kinase phosphatase-1 during acute hypertension. Hypertension. 1997;30:106-111.
48. Lai K, Wang H, Lee W-S, Jain MK, Lee M-E, Haber E. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J Clin Invest. 1996;98:1560-1567.
49. Hu Y, Cheng L, Hochleitner B-W, Xu Q. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol. 1997;17: 2808-2816.